Process Optimization (Rev IT, Complex Stabilizer)

About Mirus Bio

Mirus Bio is a long-established, private biotechnology company specializing in nucleic acid delivery (transfection) technologies. Its product portfolio, including the TransIT, VirusGEN, and AAViator platforms, serves both basic research and the rapidly growing clinical and commercial-scale manufacturing needs for viral vectors in gene therapy. With a strong publication record, extensive patent portfolio, and a shift towards GMP-grade products, the company is strategically positioned as an essential tools and reagents provider for the biopharmaceutical industry.